Johnson & Johnson has won an IDE to begin a clinical trial of the Ottava Robotic Surgical System. The New Brunswick, NJ-based company submitted for IDE approval nearly a month ago after a delay in ...

Nearly four years ago, in November 2020, MD+DI published a story with this headline: The Moment We've All Been Waiting For: J&J's Surgical Robotics Platform Reveal. The excitement around Johnson & ...

Johnson & Johnson MedTech reported that it has completed the first U.S. clinical cases of its Ottava surgical robot, with a minimally invasive gastric bypass procedure in Texas. J&J received a ...

One year after unveiling a timeline for its general surgical robot, Johnson & Johnson (J&J) has submitted an investigational device exemption (IDE) to the US Food and Drug Administration (FDA) as it ...

Johnson & Johnson MedTech has received a go-ahead from the FDA to begin human clinical trials of its Ottava surgical robot, with plans to explore its uses in laparoscopic, hybrid and open procedures.

Johnson & Johnson received U.S. FDA investigational device exemption to begin the pivotal clinical trial for the Ottava robotic surgical system. If the trial goes well, Ottava could pose a significant ...

NEW BRUNSWICK, N.J., April 14, 2025 /PRNewswire/ -- Johnson & Johnson MedTech, a global leader in surgical technologies and solutions, today announced completion of the first cases in the clinical ...

Company prepares to support clinical trial in the United States NEW BRUNSWICK, N.J., Nov. 12, 2024 /PRNewswire/ -- Johnson & Johnson MedTech, a global leader in cardiovascular, orthopaedic, surgery ...

The global surgical robot market was valued at about $4.3 billion in 2024 and is expected to reach approximately $7.4 billion by 2030, according to market research firm Grand View Research. The North ...